You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

ID: 6-23 (CED) Jan 2012
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
I. Walker, A.E. Haynes, C.T. Kouroukis